购物车
您的购物车当前为空
Timdarpacept (IMM01) 是重组 SIRPa-Fc 融合蛋白,通过阻断 CD47-SIRPa 活化机制,激活巨噬细胞,并提升抗肿瘤效能。
Timdarpacept (IMM01) 是重组 SIRPa-Fc 融合蛋白,通过阻断 CD47-SIRPa 活化机制,激活巨噬细胞,并提升抗肿瘤效能。

| 产品描述 | Timdarpacept (IMM01) is a recombinant SIRPa-Fc fusion protein that enhances antitumor activity by blocking the CD47-SIRPa interaction and activating macrophages. |
| 应用 | ELISA FACS Functional assay |
| 抗体种类 | Monoclonal |
| 缓冲液 | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| 内毒素 | <1.0 EU/mg |
| 偶联 | Unconjugated |
| CAS No. | 2749520-17-8 |
| 存储 |
对于不同动物的给药剂量换算,您也可以参考 更多